verified SJR 0,451 · Q2 • database Scopus / SJR & Web of Science indexed

United States · Informa Healthcare

workspace_premium Q2 — Drug Discovery lock Subscription

Drug Development and Industrial Pharmacy

Drug Development and Industrial Pharmacy is a journal indexed in SJR in Drug Discovery and Pharmacology with an H index of 106. It has an SJR impact factor of 0,451 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,451.

Drug Development and Industrial Pharmacy focuses its scope in these topics and keywords: release, characteristics, delivery, invitro, vitro, dermatological, influencing, cracking, directly, compatibility, ...

ISSN: 0363-9045

Publisher: Informa Healthcare

Category: Drug Discovery

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,451 Q2

H-index 106

Acceptance rate pie_chart

25% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,451

H-index

106

Docs (year)

Docs 3y

326

Total refs

5257

Cites 3y

924

Citable 3y

326

Cites/Doc 2y

2.47

Ref/Doc

54.76

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Comparison of the TSI Model 3306 Impactor Inlet with the Andersen Cascade Impactor: Solution Metered Dose Inhalers

Valproic Acid-Hydrophilic Cyclodextrin Complexes and Valproic Acid-Solid Dispersions: Evaluation of Their Potential Pharmaceutical Use

Development of a Directly Compressible Poly(Ethylene Oxide) Matrix for the Sustained-Release of Dihydrocodeine Bitartrate

Development of 400 ¬µm Pellets by Extrusion-Spheronization Application with Gelucire 50/02 to Produce a "Sprinkle" Form

Development and characterization of coated-microparticles based on whey protein/alginate using the Encapsulator device

Determination of Amorphous Content of Lactose Samples by Solution Calorimetry

Design and Evaluation of a New Transdermal Formulation Containing Chlorpheniramine Maleate

Design and Atomization Properties for an Inside-Out Type Effervescent Atomizer

Degradation Kinetics of Somatostatin in Aqueous Solution

Continuous Release of Interleukin-2 from Liposomal IL-2 (Mixture of Interleukin-2 and Liposomes) After Subcutaneous Administration to Mice

Conscious and anaesthetised Gottingen mini-pigs as anin-vivomodel for buccal absorption -pH-dependent absorption of metoprolol from bioadhesive tablets

Conditioning Following Powder Micronization: Influence on Particle Growth of Salbutamol Sulfate

SHOW MORE ARTICLES

Comparison Studies on the Percolation Thresholds of Binary Mixture Tablets Containing Excipients of Plastic/Brittle and Plastic/Plastic Deformation Properties

20-Hydroxyecdysone Release from Biodegradable Devices: the Effect of Size and Shape

Comparison of Low Shear, High Shear, and Fluid Bed Granulation During Low Dose Tablet Process Development

Comments on Drugs Difficult to Compound and the Quality of Chemicals to Be Used in Compounding

Co-delivery of gemcitabine and simvastatin through PLGA polymeric nanoparticles for the treatment of pancreatic cancer: in-vitro characterization, cellular uptake, and pharmacokinetic studies

Characterization of the Mechanism of Interaction in Ibuprofen-Eudragit RL100¬Æ Coevaporates

Basic Drug - Enterosoluble Polymer Coevaporates: Development of Oral Controlled Release Systems

Augmented anticancer activity of naringenin-loaded TPGS polymeric nanosuspension for drug resistive MCF-7 human breast cancer cells

Aqueous Preparation and Evaluation of Albumin-Chitosan Microspheres Containing Indomethacin

An Attempt to Stabilize Nilvadipine Solid Dispersion by the Use of Ternary Systems

Alginate-Coated Alginate-Polyethyleneimine Beads for Prolonged Release of Furosemide in Simulated Intestinal Fluid

A Rapid Micro Quantification Method of Paracetamol in Suppositories Using Differential Scanning Calorimetry

FAQs

Drug Development and Industrial Pharmacy has an SJR of 0,451 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for Drug Development and Industrial Pharmacy is 25%.

Drug Development and Industrial Pharmacy

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Drug Development and Industrial Pharmacy?

What is the APC / publication cost?

What is the acceptance rate?